Report

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

See allHide authors and affiliations

Science  07 Dec 2017:
eaao4572
DOI: 10.1126/science.aao4572

Log in to view full text

Log in through your institution

Log in through your institution

Subjects

Navigate This Article